Weight loss as a prognostic factor for recurrence and survival in oropharyngeal squamous cell carcinoma patients
- PMID: 30546899
- PMCID: PMC6256092
- DOI: 10.3892/mco.2018.1737
Weight loss as a prognostic factor for recurrence and survival in oropharyngeal squamous cell carcinoma patients
Abstract
Although the mortality rate of oropharyngeal squamous cell carcinoma (OPSCC) has been decreasing over the last 30 years, there has been a significant increase in the frequency of diagnosis of this type of cancer in several countries. Beyond the classic prognostic factors, such as TNM stage, there is a lack of predictive factors for recurrence and treatment response. A retrospective analysis of patients with OPSCC treated at the Oncology Department of the Santa Terezinha University Hospital between 2007 and 2012 was performed, with the aim of identifying new prognostic factors. In addition to the significance of clinical stage as a prognostic factor for recurrence, OPSCC patients with advanced TNM stage and those treated with radiotherapy, chemoradiation or palliative measures, had a worse prognosis. Patients with moderate or severe weight loss (>5%) at diagnosis had a higher tumor recurrence rate compared with those with mild or no weight loss (P=0.007). Furthermore, 76.9% of patients with moderate or severe weight loss, as opposed to 13.3% of patients with mild or no weight loss, eventually succumbed to the disease (P=0.0001). These data suggest that moderate and severe weight loss at diagnosis is a prognostic factor for OPSCC and it is associated with disease recurrence.
Keywords: oropharyngeal squamous cell carcinoma; prognostic factor; recurrence; weight loss.
Similar articles
-
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.Clin Oncol (R Coll Radiol). 2013 Nov;25(11):630-8. doi: 10.1016/j.clon.2013.07.003. Epub 2013 Jul 31. Clin Oncol (R Coll Radiol). 2013. PMID: 23916365
-
Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.Int J Clin Exp Pathol. 2014 Aug 15;7(9):5968-77. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337241 Free PMC article.
-
Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.Int J Clin Oncol. 2019 Jun;24(6):640-648. doi: 10.1007/s10147-019-01394-1. Epub 2019 Jan 29. Int J Clin Oncol. 2019. PMID: 30694402
-
Surgical Options for Locally Advanced Oropharyngeal Cancer.Curr Treat Options Oncol. 2019 Apr 1;20(5):36. doi: 10.1007/s11864-019-0621-x. Curr Treat Options Oncol. 2019. PMID: 30931485 Review.
-
Significance of Extranodal Extension in Surgically Treated HPV-Positive Oropharyngeal Carcinomas.Front Oncol. 2020 Aug 11;10:1394. doi: 10.3389/fonc.2020.01394. eCollection 2020. Front Oncol. 2020. PMID: 32850449 Free PMC article. Review.
Cited by
-
Effects of exercise therapy in cancer patients undergoing radiotherapy treatment: a narrative review.SAGE Open Med. 2020 Jun 17;8:2050312120922657. doi: 10.1177/2050312120922657. eCollection 2020. SAGE Open Med. 2020. PMID: 32595968 Free PMC article. Review.
-
Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.BMC Cancer. 2021 Jun 2;21(1):656. doi: 10.1186/s12885-021-08348-9. BMC Cancer. 2021. PMID: 34078309 Free PMC article.
-
Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation.Radiother Oncol. 2023 Mar;180:109465. doi: 10.1016/j.radonc.2023.109465. Epub 2023 Jan 11. Radiother Oncol. 2023. PMID: 36640945 Free PMC article.
-
Perioperative Blood Transfusion Is Dose-Dependently Associated with Cancer Recurrence and Mortality after Head and Neck Cancer Surgery.Cancers (Basel). 2022 Dec 23;15(1):99. doi: 10.3390/cancers15010099. Cancers (Basel). 2022. PMID: 36612096 Free PMC article.
References
-
- Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, et al. SEER cancer statistics review, 1975-2014, national Cancer Institute. http://seer.cancer.gov/csr/1975_2014/ [Jan 17th;2017 ];
LinkOut - more resources
Full Text Sources